Acquired long QT syndrome in chronic kidney disease patients

Peng Liu1, Lu Wang1,2, Dan Han1

  • 1Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.

Renal Failure
|December 28, 2019
PubMed

Insights

Acquired long QT syndrome (aLQTS) is common in chronic kidney disease (CKD) patients, increasing sudden cardiac death risk. This review covers aLQTS in CKD, focusing on management strategies.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in chronic kidney disease (CKD) patients.
  • QT interval prolongation, particularly acquired long QT syndrome (aLQTS), is linked to increased risks of torsade de pointes (TdP), sudden cardiac death (SCD), and mortality.
  • CKD patients exhibit a high prevalence of aLQTS, with prolonged QT intervals serving as an independent risk factor for SCD and overall mortality.

Purpose of the Study:

  • To review the epidemiological characteristics, risk factors, and mechanisms of aLQTS in CKD patients.
  • To discuss current and potential treatment strategies for aLQTS in the context of CKD.
  • To enhance the clinical management of aLQTS among individuals with CKD.

Main Methods:

  • Literature review focusing on studies investigating QT interval prolongation and aLQTS in CKD.
  • Analysis of epidemiological data, identified risk factors, and proposed pathophysiological mechanisms.
  • Synthesis of information on therapeutic interventions for aLQTS in CKD patients.

Main Results:

  • CKD is associated with a high prevalence of aLQTS.
  • Prolonged QT interval in CKD is a significant independent risk factor for SCD and all-cause mortality.
  • Various acquired conditions contribute to QT prolongation in CKD patients.

Conclusions:

  • Effective management of aLQTS is crucial for improving outcomes in CKD patients.
  • Further research into the specific mechanisms and targeted treatments for aLQTS in CKD is warranted.
  • Addressing aLQTS in CKD can mitigate cardiovascular risks and reduce mortality.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
486
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
252
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
221
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
505
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
709
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
293